Author:
Cornetta Kenneth,Koop Sue,Nance Emily,House Kimberley,Duffy Lisa
Reference14 articles.
1. Corrigan-Curay J, Kiem HP, Baltimore D, O'Reilly M, Brentjens RJ, Cooper L et al (2014) T-cell immunotherapy: looking forward. Mol Ther 22:1564–1574
2. June CH, Riddell SR, Schumacher TN (2015) Adoptive cellular therapy: a race to the finish line. Sci Transl Med 7:280–287
3. U.S. Food and Drug Administration (2017). FDA approves CAR-T cell therapy to treat adults with certain types of large B-cell lymphoma.
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm574058.htm
. Accessed 4 Jan 2019
4. U.S. Food and Drug Administration (2018). Axicabtagene ciloleucel.
https://www.fda.gov/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/ucm581222.htm
. Accessed 4 Jan 2019
5. Schambach A, Zychlinski D, Ehrnstroem B, Baum C (2013) Biosafety features of lentiviral vectors. Hum Gene Ther 24:132–142
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献